The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/21867
StudyName: Eligibility Metastatic Disease NCT00609401
Date of export from the portal: 02.07.2020
Date of Upload / last change: 04.05.2017
License: Creative Commons BY 4.0

----

Description: 
Study Comparing Association Between Sorafenib and Interleukin-2 (IL-2) Versus Sorafenib in 1st Line Therapy in Advanced (Adv) Renal Cell Carcinoma (RCC); ODM derived from: https://clinicaltrials.gov/show/NCT00609401
